Advertisement
Advertise Here
-
September 5, 2011 - Volume 89, Number 36
- p. 28
Business Concentrates
More Business Concentrates
- Chemical Mergers Advance
- Belgian chemical maker Solvay has almost completed its acquisition of Rhodia, having obtained close to 95% of the French firm’s shares from shareholders...
- Mitsui Changes Route To Isopropyl Alcohol
- Mitsui Chemicals will spend about $40 million to rebuild and expand its isopropyl alcohol facility in Osaka...
- Invista Resolves Butanediol Lawsuit
- Invista has resolved a lawsuit against Frontech and its owner, Ming Wan...
- Lanxess Oxide Helps London See Red
- Buckingham Palace is looking picture-perfect these days thanks in part to an iron oxide pigment manufactured by Germany’s Lanxess...
- Evonik Expands Methyl Methacrylate
- Evonik Industries is planning a series of improvement projects around the world that will expand its annual methyl methacrylate (Michael McCoyA) capacity ...
- Sika Buys Brazilian Adhesives Maker
- Sika will acquire Colauto Adesivos e Massas, a nearly 50-year-old Brazilian maker of adhesives, sealants, and acoustic damping materials...
- UOP Builds Hawaii Biorefinery
- Honeywell’s UOP subsidiary has begun construction on a biofuels demonstration facility at the Tesoro refinery in Kapolei...
- DSM, Sinochem Seal Antibiotics Deal
- DSM and Sinochem have completed a 50-50 joint venture that will own DSM’s anti-infectives business...
- Cyalume Purchases JFC Technologies
- Cyalume Technologies has acquired JFC Technologies, a fine and specialty chemical producer based in Bound Brook, N.J....
- Merck Millipore Will Acquire Amnis
- Merck Millipore, the life sciences division of Germany’s Merck KGaA, will acquire Amnis...
- Biogen, Novo Tap Adimab Technology
- Adimab has added partners looking to exploit its yeast-based antibody discovery technology...
- Fareva To Buy Pfizer Consumer Goods Plant
- Fareva, a contract manufacturer with headquarters in Luxembourg, has agreed to acquire Pfizer’s consumer products facility near Richmond, Va...
- Merck Licenses Zymeworks Process
- Merck & Co. will pay up to $187 million for access to bispecific antibody development technology from privately held Zymeworks....
- Business Roundup
- ADA-ES, Air Products & Chemicals, DMV-Fonterra, J. M. Huber, FMC, Pfizer Nutrition, Mission Therapeutics, Santhera Pharmaceuticals, Tekmira Pharmaceuticals...
Topics Covered
More Business Stories
October 24, 2011
Celanese Takes An Ethanol Plunge (Member Content)
(October 24, 2011 | Vol. 89 Issue 43 | pp. 20-21)The chemical producer seeks to make ethanol a major business but is secretive about details of its process.
Building On The Momentum (Member Content)
(October 24, 2011 | Vol. 89 Issue 43 | p. 22)BWA Water Additives rides crest of rising demand for specialty water treatment chemicals.
European Firms Invest In China
(October 24, 2011 | Vol. 89 Issue 43 | p. 6)Specialty Chemicals: Companies pursue local research and production.
Investors Bet On Cleantech
(October 24, 2011 | Vol. 89 Issue 43 | p. 9)Green Chemistry: Close to $1 billion is slated for start-up firms.
Business Concentrates (Member Content)
(October 24, 2011 | Vol. 89 Issue 43 | p. 18)
October 17, 2011
Emerging Strategies
(October 17, 2011 | Vol. 89 Issue 42 | pp. 15-26)Faced with change, pharmaceutical firms shift business mix to generics and emerging markets.
A Sense of Urgency (Member Content)
(October 17, 2011 | Vol. 89 Issue 42 | pp. 30-32)Call for drug safety pushes the mundane art of supply chain management to the front burner.
Growing Businesses The Scottish Way (Member Content)
(October 17, 2011 | Vol. 89 Issue 42 | pp. 33-35)Development authorities seek to harness industry‑academia cooperation in the life sciences.
An Update On Dow (Member Content)
(October 17, 2011 | Vol. 89 Issue 42 | pp. 36-38)CEO Andrew N. Liveris believes the major pieces are in place to continue the company's transformation.
AstraZeneca Shifts Operations
(October 17, 2011 | Vol. 89 Issue 42 | p. 10)Pharmaceuticals: Firm will add manufacturing in China while cutting jobs in the U.S.
Investment Deterrent
(October 17, 2011 | Vol. 89 Issue 42 | p. 11)Venture capital firms say FDA regulations hamper their support of biopharma companies.
Business Concentrates (Member Content)
(October 17, 2011 | Vol. 89 Issue 42 | pp. 28-30)
Honeywell’s UOP subsidiary has begun construction on a biofuels demonstration facility at the Tesoro refinery in Kapolei, on the island of Oahu, in Hawaii. The plant will convert biomass, including forest residuals, algae, and other cellulosic feedstocks, into liquid fuels using thermal processing technology. It is expected to begin production in 2012 and be fully operational in 2014. The State of Hawaii has an initiative to derive 70% of its energy from renewable sources by 2030.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © 2011 American Chemical Society
Services & Tools
ACS Resources
ACS Careers
ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers
» Join ACS
Join more than 161,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!
Popular Sections
ACS, Analytical SCENE, Business, Careers, Economy, Editor, Education, Employment, Environmental SCENE, Letters, Government, Photo Galleries, Policy, Movies, Multimedia, Nanotechnology, Newscripts, Reel Science, Safety Letters, Science, Stem Cells, Stimulus Funds, Technology, Vaccines, Videos, What's That Stuff
Advertisements
